Share-Based Compensation (Tables)

12 Months Ended

Dec. 31, 2017

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Schedule of Share-Based Compensation Expense

The following table summarizes the share-based compensation expense (in thousands):

	Year Ended December 31,
	2017			2016			2015
Numerator:
Pre-tax expense	$	7,295		$	10,202		$	7,895
Tax effect		(2,838	)		(3,846	)		(3,000	)
After tax expense	$	4,457		$	6,356		$	4,895
Denominator:
Denominator for basic shares—Weighted average shares		36,729			36,580			37,457
Denominator for diluted shares—Adjusted weighted average shares and the effect of dilutive securities		36,729			36,918			37,457
Net expense per share:
Net expense per share—basic	$	0.12		$	0.17		$	0.13
Net expense per share—diluted	$	0.12		$	0.17		$	0.13

Schedule of Intrinsic Value of Options Outstanding, Exercisable and Exercised

	As of December 31,				Year ended December 31,
	Outstanding		Exercisable		Exercised
2016	$	-	$	-	$	535
2015		1,253		1,253		902

	As of December 31,		Year ended December 31,
	Outstanding		Vested
2017	$	12,165	$	4,439
2016		29,056		4,705
2015		34,981		8,159

Schedule of Stock Options

The following table summarizes the transactions, excluding restricted stock, under the Company’s equity compensation plans for the last three years:

				Weighted					Weighted					Weighted
				Average					Average					Average
				Exercise					Exercise					Exercise
	2017			Price		2016			Price		2015			Price
Options outstanding—January 1		229,533		$	36.42		448,687		$	33.31		727,378		$	33.81
Granted		-			-		-			-		-			-
Exercised		-			-		(82,228	)		24.94		(77,918	)		24.11
Cancelled		-			-		(35,988	)		38.69		(200,773	)		38.71
Expired		(74,807	)		31.14		(100,938	)		31.13		-			-
Options outstanding—December 31		154,726		$	38.97		229,533		$	36.42		448,687		$	33.31
Number of options exercisable		154,726		$	38.97		229,533		$	36.42		195,402		$	26.11

Schedule of Proceeds Related to Option Exercises and Related Tax Benefits

The following table summarizes proceeds related to option exercises and related tax benefits for the years ended December 31, 2016 and 2015 (in thousands). In 2017, there were no options exercised.

	Years Ended December 31,
	2016		2015
Proceeds from options exercised	$	2,097	$	1,939
Tax Benefit		199		340

Schedule of Outstanding and Exercisable Options Granted

The following table summarizes outstanding and exercisable options granted under the Company’s equity compensation plans as of December 31, 2017:

			Remaining
			Contractual
Exercise Prices	Outstanding		Life (Years)		Exercisable
35.01-40.00		149,188		4.4		149,188
45.01-50.00		5,538		6.0		5,538
Total		154,726				154,726

Schedule of Restricted Stock and RSU Grants and Changes

The following table summarizes restricted stock and RSU transactions for the last three years.

				Weighted					Weighted					Weighted
				Average					Average					Average
				Grant Date					Grant Date					Grant Date
Restricted Stock and RSUs	2017			Fair Value		2016			Fair Value		2015			Fair Value
Nonvested—January 1		1,390,242		$	28.88		1,076,000		$	36.13		1,089,374		$	31.23
Granted		623,207			13.29		830,601			24.34		624,789			36.79
Vested		(307,517	)		30.67		(196,394	)		37.32		(212,537	)		33.94
Cancelled		(393,665	)		25.07		(319,965	)		36.31		(425,626	)		34.58
Nonvested—December 31		1,312,267		$	22.03		1,390,242		$	28.88		1,076,000		$	36.13